Page under construction!

The Ibandronate with or without Capecitabine in elderly patients with Early breast cancer (ICE) study is a prospective, multi-center, controlled, openlabel, randomized phase III study.

Coordinating group: GBG

Patients accrual
Start date: June 2004
Closure date: July 2008
Target nr. of patients: 1394
Final accrual: 1409

Reason for closure: reached target accrual
ClinicalTrials.gov Identifier: NCT00196859

To learn more, visit: http://germanbreastgroup.de/studien/adjuvant/ice-elderly-.html